Carotech - MIDA | Malaysian Investment Development Authority
EnglishB. Melayu日本語简体中文한국어
contrastBtngrayscaleBtn oku-icon


plusBtn crossBtn minusBtn


This site
is mobile




One of Malaysia’s home-grown success stories, Carotech Bhd. was incorporated in 1992 and is the first and only integrated plant in the world to commercially extract tocotrienol complex (Tocominâ) , a potent form of natural Vitamin E more commonly known as Super Vitamin E), mixed carotene complex (Carominâ), and phytosterols (Steromaxâ) from palm fruits (Elaeis guineensis). The extraction technology is protected through a worldwide patent – US Patent No. 5,157,132. We also recently launched a natural lycopene extract from tomatoes (Lycomaxä).

Carotech commenced production in 1995 and has since successfully carved a niche and become the leading supplier of these phytonutrients, especially the Tocominâ natural full spectrum palm tocotrienol complex, throughout the world, with the United States, Europe, Japan and Australia making up the main markets. These products are produced to the specific needs and specifications of clients and are mainly used in dietary supplements, pharmaceutical products, functional food/drinks, and cosmetic/personal care applications.

Responding to demands from customers worldwide, Carotech has, in the last few years, embarked on extensive research and development to add value to our range of phytonutrient products. It now offers an array of tocotrienol and mixed carotene products ranging from concentrated oil suspension to beadlets and water dispersible powders/emulsions for various applications. Innovation continues to accelerate within the company with the current development of novel delivery systems for optimal absorption of these phytonutrients.

In 1999, Carotech set up Carotech Incorporated, its worldwide sales and marketing office, in the United States. The new office serves to strengthen Carotech’s position in the US market and throughout the world and provide the best possible service to existing clients as well as establish new opportunities for the company.

Recognising the importance of implementing total quality control and assurance, Carotech has embarked on implementing GMP practices in the plant. Carotech’s parent company, Hovid Bhd., is one of the largest GMP-certified pharmaceutical companies in Malaysia. Highly motivated and far-sighted, Hovid, together with Carotech, have achieved many pioneering successes in the local pharmaceutical industry. Hovid manufactures well over 350 generic pharmaceutical products, health supplements, injectable products and herbal preparations.

Exporting to over 30 countries around the world, Hovid employs more than 400 employees and is a full-fledged R&D and pharmaceutical manufacturing company with the largest export portfolio among all Malaysian owned pharmaceutical companies.

Additional information can be obtained from our websites at, and